|
|
Volumn 17, Issue 1, 2007, Pages 56-58
|
|
Interferon therapy discussed at the Sixth International Conference on the Adjuvant Therapy of Malignant Melanoma, Stockholm, Sweden, 15-17 June 2006
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA2B INTERFERON;
DACARBAZINE;
PEGINTERFERON ALPHA2B;
RECOMBINANT ALPHA2B INTERFERON;
TEMOZOLOMIDE;
AUTOIMMUNITY;
CANCER ADJUVANT THERAPY;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG MEGADOSE;
HUMAN;
MELANOMA;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
SWEDEN;
TREATMENT DURATION;
ADJUVANTS, PHARMACEUTIC;
COMBINED MODALITY THERAPY;
HUMANS;
INTERFERONS;
MELANOMA;
SURVIVAL ANALYSIS;
SWEDEN;
|
|
EID: 33846463101
PISSN: 09608931
EISSN: None
Source Type: Journal
DOI: 10.1097/CMR.0b013e3280140293 Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (0)
|
